Skip to content

Pace Aid Model 53

by Cardiac Resucitator Corp.

510(k) K844811

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK844811 Date24 Jan 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DRO
Device Class
Class II
Regulation
21 CFR Part 870.5550
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Pace Aid Model 53 is an external transcutaneous cardiac pacemaker, a Class II medical device designed to deliver temporary pacing stimulation to the heart when intrinsic conduction fails. It provides non-invasive cardiac support by delivering electrical impulses through adhesive electrodes placed on the patient’s chest, facilitating rhythmic contractions in cases of bradycardia or conduction block. The device is intended for emergency and short-term use in clinical settings where internal pacing is not immediately feasible.

Supplied as a reusable device, the Pace Aid Model 53 is regulated under 21 CFR 870.5550 and holds an FDA 510(k) clearance (K844811) for substantial equivalence to prior-generation external pacemakers. It is not sterile and requires cleaning and maintenance between uses. The device is classified under product code DRO and is intended for use in hospital emergency rooms, pre-hospital settings, and cardiac care units. No MRI safety information is specified, and its operational parameters align with traditional transcutaneous pacing standards.

Other devices from Cardiac Resucitator Corp.

See all devices from Cardiac Resucitator Corp. →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What clinical scenarios is the Pace Aid Model 53 intended for, and how does it differ from permanent pacing solutions?

    The Pace Aid Model 53 is designed for emergency and short-term cardiac support when a patient’s natural heart rhythm fails, such as in cases of severe bradycardia or conduction block. Unlike permanent pacemakers, it is non-invasive, delivering electrical impulses through adhesive electrodes on the chest to stimulate the heart temporarily. It is specifically intended for settings like hospital emergency rooms, pre-hospital care, or cardiac care units where internal pacing isn’t immediately feasible. It is not meant for long-term use or as a standalone solution for chronic heart conditions.

  • Is the Pace Aid Model 53 single-use or reusable, and what maintenance does it require between patients?

    The Pace Aid Model 53 is a reusable device, not intended for single-use. After each use, it requires cleaning and maintenance to ensure proper function and hygiene for subsequent patients. Since it is not sterile, reprocessing protocols must follow manufacturer guidelines to prevent contamination and maintain performance.

  • Where can this device legally be used, and what regulatory approvals does it hold?

    The Pace Aid Model 53 is FDA-cleared under a 510(k) submission (K844811) and classified as a Class II medical device, regulated under 21 CFR 870.5550. It is intended for use in hospital emergency rooms, pre-hospital settings, and cardiac care units in the U.S. The clearance establishes its substantial equivalence to prior-generation external pacemakers, ensuring it meets traditional transcutaneous pacing standards.

  • Does the Pace Aid Model 53 come with specific electrode sizes or configurations, and how are they applied?

    The device specifications do not detail electrode sizes or configurations in the provided data, but as a transcutaneous pacemaker, it relies on adhesive electrodes placed on the patient’s chest to deliver stimulation. The exact placement (e.g., V1/V6 or other leads) would follow standard emergency cardiac pacing protocols, typically guided by clinical training and institutional guidelines. The manufacturer’s instructions would outline proper application techniques.

  • Are there any restrictions on storage or environmental conditions for the Pace Aid Model 53?

    The provided data does not specify storage requirements beyond standard medical device handling. However, as a reusable device, it should be stored in a clean, dry environment to prevent damage or contamination between uses. Since it is not sterile, it should not be exposed to conditions that could compromise its functionality or hygiene, such as extreme temperatures or humidity.